PURPOSE:Regular exercise and healthy eating are routinely recommended for breast cancer survivors, and past studies show benefits in quality of life and decreased inflammation. However, this has not been tested specifically in triple-negative breast cancer survivors. Increasing physical activity and losing body fat are thought to positively affect inflammatory biomarkers that have been associated with breast cancer. Therefore, the primary purpose of this study was to determine if participation in an exercise and dietary counseling program can improve body fat, physical function, and quality of life in survivors of this aggressive breast cancer. Secondarily, we sought to determine if participation in the program had beneficial effects on obesity-related markers of the adipokine profile. METHODS:Sixty-six survivors of triple-negative breast cancer with BMI >25 were invited to participate. Twenty-eight enrolled and 23 completed the randomized, controlled trial (13 intervention, 10 control). Moderate-intensity aerobic exercise (150 min per week, for 12 weeks) and diet counseling were compared to usual care, education only. The primary outcome of interest was weight loss (body mass, BMI, % fat), and secondary outcomes included physical function (exercise capacity), quality of life (Function After Cancer Therapy-Breast (FACT-B)), cytokines (C-reactive protein (CRP), TNF-α, IL-6), and adipokine profile (leptin, adiponectin, insulin). RESULTS: Participants in the program lost more body fat (2.4 % loss vs. 0.4 % gain, p < 0.05) than the control group. The intervention group also improved quality of life (FACT-B total score +14 pts) and decreased sedentary time but did not improve peak exercise capacity. The intervention had no effect on serum cytokines and adipokines after 12 weeks in the program. However, serum leptin and adiponectin and their ratio were significantly correlated with BMI in the intervention group (p < 0.05). CONCLUSIONS:Exercise and dietary counseling led to loss of body fat and improved quality of life in survivors of triple-negative breast cancer. BMI was associated with favorable changes in leptin and adiponectin which may reflect a change in adiposity with intervention. Exercise and healthy eating may be equally effective in this high-risk population as in other breast cancer survivors and should be encouraged as a part of a cancer survivorship program.
RCT Entities:
PURPOSE: Regular exercise and healthy eating are routinely recommended for breast cancer survivors, and past studies show benefits in quality of life and decreased inflammation. However, this has not been tested specifically in triple-negative breast cancer survivors. Increasing physical activity and losing body fat are thought to positively affect inflammatory biomarkers that have been associated with breast cancer. Therefore, the primary purpose of this study was to determine if participation in an exercise and dietary counseling program can improve body fat, physical function, and quality of life in survivors of this aggressive breast cancer. Secondarily, we sought to determine if participation in the program had beneficial effects on obesity-related markers of the adipokine profile. METHODS: Sixty-six survivors of triple-negative breast cancer with BMI >25 were invited to participate. Twenty-eight enrolled and 23 completed the randomized, controlled trial (13 intervention, 10 control). Moderate-intensity aerobic exercise (150 min per week, for 12 weeks) and diet counseling were compared to usual care, education only. The primary outcome of interest was weight loss (body mass, BMI, % fat), and secondary outcomes included physical function (exercise capacity), quality of life (Function After Cancer Therapy-Breast (FACT-B)), cytokines (C-reactive protein (CRP), TNF-α, IL-6), and adipokine profile (leptin, adiponectin, insulin). RESULTS:Participants in the program lost more body fat (2.4 % loss vs. 0.4 % gain, p < 0.05) than the control group. The intervention group also improved quality of life (FACT-B total score +14 pts) and decreased sedentary time but did not improve peak exercise capacity. The intervention had no effect on serum cytokines and adipokines after 12 weeks in the program. However, serum leptin and adiponectin and their ratio were significantly correlated with BMI in the intervention group (p < 0.05). CONCLUSIONS: Exercise and dietary counseling led to loss of body fat and improved quality of life in survivors of triple-negative breast cancer. BMI was associated with favorable changes in leptin and adiponectin which may reflect a change in adiposity with intervention. Exercise and healthy eating may be equally effective in this high-risk population as in other breast cancer survivors and should be encouraged as a part of a cancer survivorship program.
Authors: Tiina Saarto; Heidi Marika Penttinen; Harri Sievänen; Pirkko-Liisa Kellokumpu-Lehtinen; Liisa Hakamies-Blomqvist; Riku Nikander; Riikka Huovinen; Riitta Luoto; Hannu Kautiainen; Salme Järvenpää; Irja Idman; Meri Utriainen; Leena Vehmanen; Anna-Stina Jääskeläinen; Anneli Elme; Johanna Ruohola; Tiina Palva; Harri Vertio; Matti Rautalahti; Mikael Fogelholm; Carl Blomqvist; Minna-Liisa Luoma Journal: Anticancer Res Date: 2012-09 Impact factor: 2.480
Authors: Jennifer A Ligibel; Jeffrey Meyerhardt; John P Pierce; Julie Najita; Laura Shockro; Nancy Campbell; Vicky A Newman; Leslie Barbier; Eileen Hacker; Marie Wood; James Marshall; Electra Paskett; Charles Shapiro Journal: Breast Cancer Res Treat Date: 2011-11-24 Impact factor: 4.872
Authors: Lee W Jones; Kerry S Courneya; John R Mackey; Hyman B Muss; Edith N Pituskin; Jessica M Scott; Whitney E Hornsby; April D Coan; James E Herndon; Pamela S Douglas; Mark Haykowsky Journal: J Clin Oncol Date: 2012-05-21 Impact factor: 44.544
Authors: Christie A Befort; Jennifer R Klemp; Heather L Austin; Michael G Perri; Kathryn H Schmitz; Debra K Sullivan; Carol J Fabian Journal: Breast Cancer Res Treat Date: 2011-12-25 Impact factor: 4.872
Authors: Ikuyo Imayama; Cornelia M Ulrich; Catherine M Alfano; Chiachi Wang; Liren Xiao; Mark H Wener; Kristin L Campbell; Catherine Duggan; Karen E Foster-Schubert; Angela Kong; Caitlin E Mason; Ching-Yun Wang; George L Blackburn; Carolyn E Bain; Henry J Thompson; Anne McTiernan Journal: Cancer Res Date: 2012-05-01 Impact factor: 12.701
Authors: Sara B Jones; Gwendolyn A Thomas; Sara D Hesselsweet; Marty Alvarez-Reeves; Herbert Yu; Melinda L Irwin Journal: Cancer Prev Res (Phila) Date: 2012-12-04
Authors: Sandra C Hayes; Sheree Rye; Tracey Disipio; Patsy Yates; John Bashford; Chris Pyke; Christobel Saunders; Diana Battistutta; Elizabeth Eakin Journal: Breast Cancer Res Treat Date: 2012-11-09 Impact factor: 4.872
Authors: E Scott; A J Daley; H Doll; N Woodroofe; R E Coleman; N Mutrie; H Crank; H J Powers; J M Saxton Journal: Cancer Causes Control Date: 2012-11-27 Impact factor: 2.506
Authors: Karen Basen-Engquist; Catherine M Alfano; Melissa Maitin-Shepard; Cynthia A Thomson; Kathryn H Schmitz; Bernardine M Pinto; Kevin Stein; David S Zucker; Karen L Syrjala; Elizabeth Fallon; Colleen Doyle; Wendy Demark-Wahnefried Journal: Obesity (Silver Spring) Date: 2017-11 Impact factor: 5.002
Authors: Jeanne M Ferrante; Katie A Devine; Alicja Bator; Ashley Rodgers; Pamela A Ohman-Strickland; Elisa V Bandera; Kevin O Hwang Journal: Transl Behav Med Date: 2020-10-08 Impact factor: 3.046
Authors: Ashlea Braun; James Portner; Elizabeth M Grainger; Emily B Hill; Gregory S Young; Steven K Clinton; Colleen K Spees Journal: J Nutr Educ Behav Date: 2018-01 Impact factor: 3.045
Authors: Emily Cox-Martin; Lisa H Trahan; Matthew G Cox; Patrick M Dougherty; Emily A Lai; Diane M Novy Journal: Support Care Cancer Date: 2017-01-26 Impact factor: 3.603
Authors: Jessica M Scott; Emily C Zabor; Emily Schwitzer; Graeme J Koelwyn; Scott C Adams; Tormod S Nilsen; Chaya S Moskowitz; Konstantina Matsoukas; Neil M Iyengar; Chau T Dang; Lee W Jones Journal: J Clin Oncol Date: 2018-06-12 Impact factor: 44.544